The Greenwall Foundation has selected Bill of Health co-editor, Glenn Cohen, to receive a Faculty Scholar Award in Bioethics for 2012-2015. This career development award is intended to enable outstanding junior faculty members to carry out original research that will help…
We’re excited to introduce and welcome our first guest blogger of the Fall semester, Nadia Sawicki. (And note that we’ve already introduced a ton of other bloggers below – you can also get to their…
by Suzanne M. Rivera, Ph.D. For legitimate reasons, the human research enterprise frequently is regarded with suspicion. Despite numerous rules in place to protect research participants’ rights and welfare, there is a perception that research…
By Hyeongsu Park In May 2012, Health Canada granted market authorization for Prochymal. This decision is the world’s first regulatory approval of a stem cell drug (as well as the first therapy for acute graft-vs-host…
Following up on his post on Australia, Al Roth notes that American medicine is a market with tightly restricted entry, at all levels. Proposed legislation offers a glimpse: Bill Would Create More Medical-Residency Slots, Potentially Easing Physician…
By Adriana Lee Benedict The 14th round of negotiations for the Trans-Pacific Partnership Agreement (TPPA, a multilateral trade agreement currently being negotiated by the USTR and 10 other countries) is currently underway in Leesburg, VA.…
So…it’s a bit late today, but each Friday we’ll be posting some highlights from the Yale Interdisciplinary Center for Bioethics newsletter (AKA “Frimail”), a really fantastic resource for those of us interested in what’s been going…
Al Roth has come across a troubling phenomenon in Australia, where medical internships are in short supply. Medical students languish in a critical condition The Australian Medical Students’ Association estimates almost 500 students will miss…
By Nicolas Terry Kathleen Boozang, The New Relators: In-House Counsel and Compliance Officers, SSRN David Asch & Kevin Volpp, What Business Are We In? The Emergence of Health as the Business of Health Care, NEJM…
By Katie Booth The FDA Law Blog has just published a semi-serious study by Kurt Karst on the growth of Title 21 of the United States Code (“USC”) compared to Title 21 of the Code of…
